Xiaopeng Peng

5PUBLICATIONS
2CO-AUTHORS
Molecular targetsPharmacogenomicsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 15, 2025
Discovery of Dual PD-L1/HDAC3 Inhibitors for Tumor Immunotherapy.

Zhijie Wang, HaiQi He, Xiaotong Liao

|Jan 23, 2025
Discovery of Novel Hydrazide-Based HDAC3 Inhibitors as Epigenetic Immunomodulators for Cancer Immunotherapy.

Zhiqiang Sun, Jinmei Cheng, Chenglong Xu

Pageof 1